Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.74
Delayed Data
As of May 26
 -0.01 / -0.11%
Today’s Change
5.21
Today|||52-Week Range
30.13
-13.12%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close8.75
Today’s open8.74
Day’s range8.51 - 8.94
Volume443,103
Average volume (3 months)874,689
Market cap$298.4M
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-73.20%
Earnings growth (this year)-25.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
CNCEConcert Pharmaceutic...-0.08-0.60%
AGTCApplied Genetic Tech...-0.18-1.11%
ARDXArdelyx Inc-0.10-1.14%
CRVSCorvus Pharmaceutica...+0.10+0.70%
Data as of 05/26/2016

Financials

Next reporting dateJune 13, 2016
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$47.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
COO, Secretary, Director &
Head-Investor Relations
Gregory T. Mayes
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers

Search for Jobs